These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9262750)

  • 1. Appropriateness of maximum-dose guidelines for vincristine.
    McCune JS; Lindley C
    Am J Health Syst Pharm; 1997 Aug; 54(15):1755-8. PubMed ID: 9262750
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincristine: Can its therapeutic index be enhanced?
    Moore A; Pinkerton R
    Pediatr Blood Cancer; 2009 Dec; 53(7):1180-7. PubMed ID: 19588521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
    Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
    Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
    Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
    Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accidental intrathecal injection of vincristine.
    Root T
    J Oncol Pharm Pract; 2005 Mar; 11(1):35. PubMed ID: 16460602
    [No Abstract]   [Full Text] [Related]  

  • 6. Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study.
    Uittenboogaard A; van de Velde M; van de Heijden L; Mukuhi L; de Vries N; Langat S; Olbara G; Huitema ADR; Vik T; Kaspers G; Njuguna F
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31160. PubMed ID: 38956809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN's Commitment to Medication Safety: The Vincristine Initiative.
    Sugalski J; Stewart FM; Carlson RW
    J Natl Compr Canc Netw; 2016 Aug; 14(8):959-60. PubMed ID: 27496111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
    van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
    Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral phrenic nerve plasy: a rare manifestation of vincristine neurotoxicity: correspondence.
    Moriya K; Kakisaka Y; Onuma M; Sasahara Y; Kure S
    Indian J Pediatr; 2014 Dec; 81(12):1429. PubMed ID: 24652272
    [No Abstract]   [Full Text] [Related]  

  • 11. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Sep; 81(9):957-8. PubMed ID: 23801349
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral phrenic nerve palsy: a rare manifestation of vincristine neurotoxicity: authors' reply.
    Dhingra D; Sethi GR; Mantan M
    Indian J Pediatr; 2014 Dec; 81(12):1430. PubMed ID: 24652271
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coroner 'implores' hospitals to change cancer drug syringe.
    Nurs Times; 2001 Feb 8-14; 97(6):7. PubMed ID: 11954252
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients.
    Velasco R; Petit J; Clapés V; Verdú E; Navarro X; Bruna J
    J Peripher Nerv Syst; 2010 Mar; 15(1):17-25. PubMed ID: 20433602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
    Silverman JA; Reynolds L; Deitcher SR
    J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Vincristine overdosage in paediatric patients".
    Stones DK
    Med Pediatr Oncol; 1998 Mar; 30(3):193. PubMed ID: 9434832
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug administration. A fatal error of judgement.
    Gulland A
    Nurs Times; 2001 Feb 1-7; 97(5):11. PubMed ID: 11954166
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-4 protects from chemotherapy-induced peripheral neuropathy in mice modal via the stimulation of IL-4/STAT6 signaling.
    Shi Q; Cai X; Shi G; Lv X; Yu J; Wang F
    Acta Cir Bras; 2018 Jun; 33(6):491-498. PubMed ID: 30020310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.